These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20112721)

  • 1. [Effection of Qing-Xuan tablets on behavior pattern and striatal TNF-alpha of Parkinson model mice].
    Yang XX; Yang L; Huo QL; Liu MN; Lin XX; Liu SJ
    Zhong Yao Cai; 2009 Oct; 32(10):1560-3. PubMed ID: 20112721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroprotective effects and mechanisms of Chuanxiong Chatiao pulvis against MPTP-induced dopaminergic neurotoxicity in mice model of Parkinson's disease].
    Shu D; He J; Chen J
    Zhongguo Zhong Yao Za Zhi; 2009 Oct; 34(19):2494-7. PubMed ID: 20067021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the oil from ganoderma lucidum spores on pathological changes in the substantia nigra and behaviors of MPTP-treated mice].
    Zhu WW; Liu ZL; Xu HW; Chu WZ; Ye QY; Xie AM; Chen L; Li JR
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):667-71. PubMed ID: 15958304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
    Pinna A; Tronci E; Schintu N; Simola N; Volpini R; Pontis S; Cristalli G; Morelli M
    Neuropharmacology; 2010 Mar; 58(3):613-23. PubMed ID: 19951715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.
    Luchtman DW; Shao D; Song C
    Physiol Behav; 2009 Aug; 98(1-2):130-8. PubMed ID: 19410592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
    Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
    Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K; Kondo T; Narabayashi H
    No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.
    O'Neill MJ; Murray TK; Whalley K; Ward MA; Hicks CA; Woodhouse S; Osborne DJ; Skolnick P
    Eur J Pharmacol; 2004 Feb; 486(2):163-74. PubMed ID: 14975705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.
    Li X; Yin J; Cheng CM; Sun JL; Li Z; Wu YL
    Chin Med J (Engl); 2005 Aug; 118(16):1357-61. PubMed ID: 16157030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice.
    Sakai R; Irie Y; Murata T; Ishige A; Anjiki N; Watanabe K
    Phytother Res; 2007 Sep; 21(9):868-73. PubMed ID: 17486689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease.
    Geng X; Tian X; Tu P; Pu X
    Eur J Pharmacol; 2007 Jun; 564(1-3):66-74. PubMed ID: 17359968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and biochemical effects of 4-phenylpyridine, 2-phenylpyridine, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rodents.
    Hassan MN; Thakar JH; Grimes JD
    Adv Neurol; 1990; 53():219-23. PubMed ID: 2239461
    [No Abstract]   [Full Text] [Related]  

  • 18. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
    Mizukawa K; Ogawa N; Sora YH
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.
    Kurkowska-Jastrzebska I; Litwin T; Joniec I; Ciesielska A; Przybyłkowski A; Członkowski A; Członkowska A
    Int Immunopharmacol; 2004 Oct; 4(10-11):1307-18. PubMed ID: 15313429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of tripchlorolide on dopaminergic neurons in partially lesioned rat model of Parkinson's disease].
    Cheng XX; Li FQ; Huang M; Wang XM; Han JS
    Yao Xue Xue Bao; 2002 May; 37(5):339-42. PubMed ID: 12579836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.